Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Chronic > Chapter 15 > Flashcards

Chapter 15 Flashcards

1
Q

Cite the 2 major dysfunctions in cellular regulation which are needed for cancer development.

A

Defective cell proliferation (growth) and defective cell differentiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain how cancerous cells proliferate by loss of contact inhibition and the pyramid effect.

A

*Normal cells respect the boundaries and territory of the cells surrounding them
*Cancer cells grown in tissue culture have a loss of contact inhibition. They have no regard for cell boundaries and grow on top of one another and on top of or between normal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the function of tumor suppressor genes and what inactivates them.

A

*Tumor suppressor genes regulate cell growth. They prevent cells from going through the cell cycle. Mutations can change tumor suppressor genes and make them inactive. THis results in a loss of their tumor-suppressing action.
*Eg: BRCA1 and BRCA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name the 3 stages of cancer development.

A
  1. Initiation
  2. Promotion
  3. Progression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give examples of cancer promoting factors and what could be done to reduce the risk of cancer (4ex.)

A

*ex. dietary fat, cigarette smoking, alcohol use
*decreasing or complete cessation of each would decrease risk of developing cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define the latent period of stage 2 and what needs to occur before cancer can be detected (3)

A

*length of time from when 1st genetic alteration occurs and the actual clinical evidence of cancer
*may range 10-40 years
*for diseases to be clinically evident, tumor must reach a critical mass that can be detached.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe characteristics of the 3rd stage, progression, in cancer development.

A

Characterized by:
1. increase in growth rate of tumor
2. invasiveness
3. metastasis: spread of cancer to distant site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cite the 5 main sites of metastasis.

A

1.Lungs
2. Liver
3. Bone
4. Brain
5. Adrenal glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Briefly describe the metastatic process and the importance of tumor angiogenesis. (3)

A

(1) rapid growth of the primary tumor
(2) tumor angiogenesis
(3) penetration of walls of lymph or vascular vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tumor angiogenesis

A

the process of the formation of blood vessels within the tumor itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hematogenous metastasis: (3)

A
  1. penetrate blood vessels,
  2. travel through blood throughout body,
  3. adhere to and penetrate small blood vessels of distant organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fungating tumors

A

have a rich blood supply below them, very difficult to operate on these, need to cauterize, huge wounds, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

most common sites of metastases:

A

lungs, liver, bones and brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Compare sentinel lymph node and skip metastasis.

A

sentinel lymph node: 1st node confronted as tumor cell spreads through the lymphatic system

skip metastasis: when tumor can travel to distant nodes by bypassing local lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the importance of cancer classification systems. (4)

A
  1. communicates w/ healthcare team
  2. prep and eval tx plan
  3. determine prognosis
  4. compare groups statistically
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anatomic site

three classifications

A

*IDs tissue by origin, atomic site, and behavior of tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

carcinomas originate from

A

*embryonal ectoderm (skin, glands)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sarcomas originate from

A

embryonal mesoderm (connective tissue, muscle, bone, and fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lymphomas and leukemias originate from

A

hematopoietic system

20
Q

Histological classification (2)

A

*appearance of cells and degree of differentiation are evaluated to determine how closely cells resemble tissues of origin
*Poorly differentiated tumors have a poorer prognosis than those closer in appearance to normal cells

21
Q

Histological classification grades (5)

A

Grade I: mild dysplasia, well differentiated

Grade II: moderate dysplasia, moderately differentiation

Grade III: severe dysplasia, poorly differentiated

Grade IV: cells are immature, primitive (anaplasia), and undifferentiated; cell of origin is hard to determine

Grade X: cannot be assessed

22
Q

clinical staging

A

Based on extent and spread of disease

23
Q

clinical staging stages (5)

A

Stage 0: cancer in situ (localized, no invasion or metastasis)

Stage I: Tumor limited to tissue of origin, localized growth

Stage II: Limited local spread

Stage III: extensive local and regional spread

Stage IV: metastasis

24
Q

explain the 3 goals of cancer treatment:

A

cure, control and palliation

25
Q

Cure (2)

A

*surgery alone or periods of adjunctive systemic therapy (chemo)

*timeframe to “cure” may differ according to the tumor and its characteristics

26
Q

Control

A

Patients may undergo an initial course of treatment followed by maintenance therapy for as long as the disease is responding.
* Patients are monitored closely for early signs and symptoms of disease recurrence or progression and the cumulative effects of therapy.

27
Q

Palliative goal (3)

A

*relief or control of symptoms
*maintain quality of life
*Palliative care and treatment are not mutually exclusive and can take place concurrently

28
Q

Describe the surgical approaches to cancer treatment: cure or control (2)

A

*remove only as much tissue as necessary and spare normal tissue
*A debulking or cytoreductive procedure may be used if the tumor cannot be completely removed (eg: a tumor attached to a vital organ)

29
Q

Describe the surgical approaches to cancer treatment: prevention (3)

A

*surgery used to eliminate or reduce risk of cancer in at risk pts
*prophylactic removal of nonvital organs
*usual sites of regional spread may be removed

30
Q

Describe the surgical approaches to cancer treatment: supportive & palliation

A

(done when cure and control are no longer possible)
*insertion of gastric feeding tube
*placement of CV access device
*Prophylactic surgical fixation of bones at risk for pathologic fracture

31
Q

Describe 4 types of regional delivery methods of chemotherapy and the main advantage of this type of delivery.

A
  1. Intraarterial chemotherapy
  2. Intraperitoneal chemotherapy
  3. Intrathecal or Intraventricular chemotherapy
  4. Intravesical bladder chemotherapy
32
Q

Intraarterial chemotherapy (what + what it is tx for)

A

*delivers the drug to the tumor through the arteries supplying the tumor
*tx for osteogenic sarcoma; cancers of the head and neck, bladder, and cervix; melanoma; primary liver cancer; and metastatic liver disease

33
Q

Intraperitoneal chemotherapy: (what + what it is tx for)

A

involves the delivery of chemotherapy to the peritoneal cavity.

*tx for peritoneal metastases from primary colorectal and ovarian cancers and malignant ascites.

34
Q

Intrathecal or Intraventricular chemotherapy

A

*tx for metastasis to the CNS
*This method involves a lumbar puncture and injection of chemotherapy into the subarachnoid space

35
Q

Intravesical bladder chemotherapy:

A

*instilling chemotherapy into the bladder through catheter and letting it sit for 1-3hrs

36
Q

Explain acute, delayed, and chronic adverse effects of chemotherapy on normal tissue: acute (2)

A

*Acute: Occurs during and right after drug administration.
*It includes anaphylactic and hypersensitivity reactions, extravasation or a flare reaction, anticipatory nausea and vomiting, and dysrhythmias

37
Q

Explain acute, delayed, and chronic adverse effects of chemotherapy on normal tissue: delayed (8s/s)

A

They include delayed nausea and vomiting, mucositis, alopecia, skin rashes, bone marrow suppression, altered bowel function (diarrhea, constipation), and a variety of cumulative neurotoxicities.

38
Q

Explain acute, delayed, and chronic adverse effects of chemotherapy on normal tissue: chronic (2)

A

*Involve damage to organs, such as the heart, liver, kidneys, and lungs.
*Chronic toxicities can be either long-term effects that develop during or right after treatment and persist

39
Q

Describe the effects of ionizing radiation on cancerous cells (6)

A

*Delivery of high-energy beams, when absorbed into tissue, produces ionization of atomic particles. The energy in ionizing radiation acts to break the chemical bonds in DNA. The DNA is damaged, causing cell death.

*bone marrow suppression, fatigue, GI probs, integ/muscle reactions, pulmonary effects, and reproductive issues

40
Q

Contrast external beam vs internal radiation (brachytherapy).

A

*external (teletherapy): most common. pt exposed to Rad from mega volt machine
*internal (brachytherapy): implantation/insertion of radioactive material into or close to tumor. Minimal exposure to healthy tissues. Often used in combo w/ external

41
Q

Estimate the reasons for late effects of radiation and chemotherapy.

A

*SE if chemo/rad that occur mohts to years after remission. Once they occur may be progressive and generally permanent
*Ex: skin telangiectasias to strictures, fistulas, or radiation necrosis.
*the additive effects of malignant chem b4, during, or after course of rad therapy can significantly increase resulting late effects
*most at risk pts are txed w/ alkylating agents w/ high-dose rad

42
Q

Describe the manifestations of cancer cachexia and relationship with morbidity. (4)

A

*wasting syndrome: anorexia and or unintentional wt loss

*characterized by: generalized tissue wasting, skeletal muscle atrophy, immune dysfunction, metabolic abnorms

*tx: wt loss cannot be reversed nutritionally (increased risk of mortality)

*best management is to tx cancer, 2nd best is to increase nutrition, 3rd is to use megestrol to sim appetite.

43
Q

List 3 reasons why cancer patients experience life threatening infections.

A
  1. Ulceration and necrosis caused by the tumor
  2. The tumor compressing vital organs
  3. Neutropenia from the cancer or cancer treatment
44
Q

Describe gerontological considerations when determining cancer treatments.

A

*cancer s/s may be mistaken for age-related changes
*OAs are more vulnerable to complications of cancer and cancer tx
*functional status should be considered when a tx plan is selected
*benefits and risks of tx should be carefully considered.

45
Q
A

Chronic (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions